info icon

This is a non-core endpoint: only basic statistics are computed.

Dental invagination

K11_DENTAL_INVAGINAT

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 K00.25
  • Cause of death: ICD-10 K00.25

2 out of 7 registries used, show all original rules.

14

4. Check minimum number of events

None

14

5. Include endpoints

None

14

6. Filter based on genotype QC (FinnGen only)

14

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 193 94 98
Only index persons 155 80 75
Unadjusted period prevalence (%)
Whole population 0.00 0.00 0.00
Only index persons 0.00 0.00 0.00
Median age at first event (years)
Whole population 12.53 13.32 11.59
Only index persons 14.93 15.94 13.85

-FinnGen-

Key figures

All Female Male
Number of individuals 14 6 8
Unadjusted period prevalence (%) 0.00 0.00 0.00
Median age at first event (years) 33.64 41.68 27.61

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1761868) Lipid panel - Serum or Plasma
8
39
3.42
1.48
2.1
2.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
8
40
3.30
1.44
4.3
5.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
5
20
3.30
1.27
4.2
3.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
5
21
3.12
1.20
1.0
2.6
u/l
53.4
62.2
—
5
21
(3033658) Prothrombin time (PT) actual/Normal
5
23
2.80
0.87
2.6
9.6
%
99.4
90.5
—
5
23
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
5
28
2.21
0.74
3.4
4.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
0
21
0.00
0.66
0.0
1.8
—
1.1
—
0
15
(3013826) Glucose [Moles/volume] in Serum or Plasma
8
53
2.18
0.60
5.8
11.0
mmol/l
6.5
6.5
—
8
47
(3037467) Urinalysis macro (dipstick) panel - Urine
9
68
1.90
0.40
1.8
3.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
5
36
1.60
0.28
2.4
3.3
nmol/l
85.0
73.7
—
5
30
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.22
0.0
1.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
0
12
0.00
0.22
0.0
1.8
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
0
12
0.00
0.22
0.0
5.1
—
256.5
—
0
12
(3003458) Phosphate [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
13.3
—
1.3
—
0
13
(3001604) Monocytes [#/volume] in Blood
6
53
1.23
0.11
2.2
6.5
e9/l
0.7
0.5
—
6
47
(3006315) Basophils [#/volume] in Blood
6
53
1.23
0.11
2.0
6.6
e9/l
0.1
0.0
—
6
47
(3013650) Neutrophils [#/volume] in Blood by Automated count
7
60
1.33
0.11
4.6
8.5
e9/l
4.1
4.0
—
7
52
(3019198) Lymphocytes [#/volume] in Blood
6
54
1.19
0.11
2.3
6.6
e9/l
2.4
1.9
—
6
49
(3013115) Eosinophils [#/volume] in Blood
6
55
1.16
0.11
2.3
6.7
e9/l
0.2
0.2
—
6
49
(3044889) 12 lead EKG panel
6
57
1.09
0.00
2.5
2.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
0
8
0.00
0.00
0.0
3.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
5
48
1.06
0.00
8.0
8.1
e9/l
0.0
0.0
—
5
36
(3016879) Cocaine [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
1.5
—
0
5
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(1002224) Polysomnography panel
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
10.0
—
4.6
—
0
5
(42529406) Shigella sp [Presence] in Stool by Culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
0
7
0.00
0.00
0.0
15.3
—
82.9
—
0
7
(3019060) Gas panel - Arterial blood
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint K11_DENTAL_INVAGINAT and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_DENTAL_INVAGINAT.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: K11_DENTAL_INVAGINAT – Dental invagination

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data